Are there precautions I should take before our annual trip to the beach?

 

Q: Are there precautions I should take before our annual trip to the beach? 

A: While undergoing cancer treatment, you need to be more cautious than usual about spending time in the sun. That means covering up exposed skin with protective clothing and using sunblock (SPF 30 and higher is good), whether you’re dashing through the waves or skiing down snowy slopes. Avoid direct sun for prolonged periods, especially during the peak hours of 10 a.m. to 3 p.m. Be sure to apply sunscreen frequently, cover up, wear a hat, and stay in the shade as much as possible.

Chemotherapy makes you more sensitive to the sun’s ultraviolet rays, so your skin burns more easily. This sensitivity goes away after treatment ends. Radiation leaves permanent changes to your skin. Going forward, you’ll always need to be extra careful about providing sun protection for skin areas that received radiation.  
--Kathy Newman, RN, BSN

Your skin may also darken from hyperpigmentation, a side effect of chemotherapy.

Latest Cancer News
Neoadjuvant Chemotherapy for High-risk Localized Prostate Cancer Is Safe and Effective

March 19, 2010 — Neoadjuvant treatment with Taxotere® (docetaxel) and Emcyt® (estramustine) for high-risk localized prostate cancer appears to be safe and produces promising responses compared with standard treatment, according to the results of a Phase III randomized study presented at the 2010 Genitourinary Cancers Symposium in San Francisco.

Type of Specialist Seen Affects Treatment Decisions for Men with Prostate Cancer

March 19, 2010 — Researchers from several U.S. medical centers have reported that “specialist visits relate strongly to prostate cancer treatment choices.” The details of this study were published in the March 8, 2010 issue of the Archives of Internal Medicine.

Tobacco Usage Affects Risk of Metastases of HPV-related Oropharynx Cancer

March 19, 2010 — Researchers from the University of Michigan have reported that current tobacco users with advanced, human papillomavirus (HPV)-positive oropharyngeal cancer are at increased risk of disease recurrence. The details of this study were published in the February 15, 2010 issue of Clinical Cancer Research.

Select news items provided by Reuters Health